Today, I had the opportunity to speak with Amogha Tadimety, PhD, CEO, and Alison Burklund, PhD, President & CTO, co-founders of Nanopath, an innovative company specializing in women’s health diagnostics. Both hailing from Dartmouth’s Thayer School of Engineering, Amogha and Alison walk us through the challenges and opportunities of founding a diagnostic company during the COVID era. We chatted about the intricacies of bringing foundational technology to consumers, including the importance of navigating the insurance system and the specific focus of their technology on improving point-of-care diagnostics in women's health. They highlighted the need for innovative tools in OB-GYN practices, the strategic decisions that shaped Nanopath's direction, and the significant milestones they have achieved. They also emphasized the importance of building a strong team and network, overcoming healthcare system challenges, and their vision for the company's future, which includes creating a comprehensive well-woman panel and expanding the technology for broader applications.
Connect with us!
Link In with Carina
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction to Nanopath Founders
00:59 Career Paths and Early Inspirations
01:42 The PhD Innovation Program
02:16 Founding Nanopath: The Journey Begins
04:58 Nanopath's Mission and Technology
08:13 Navigating the Healthcare System
10:14 Challenges and Opportunities During COVID-19
16:05 Building a Strong Team and Network
24:02 Future Vision and Goals
25:38 Reading Recommendations and Closing Thoughts
